Literature DB >> 7923440

Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain.

J Hidalgo1, A García, A M Oliva, M Giralt, T Gasull, B González, H Milnerowicz, A Wood, I Bremner.   

Abstract

The knowledge of brain metallothionein (MT) regulation and especially of MT presence in specific cell types is scarce. Therefore, the effect of several well-known MT inducers, measured by radioimmunoassays using antibodies that cross-react with MT-I and MT-II or specific for MT-I and which do not cross-react with human growth inhibitory factor (GIF or MT-III), has been studied in primary cultures of neurons or astrocytes obtained from rat cerebrum. MT-I levels in glial cells were about ten times higher than those in neuronal cells (538 +/- 194 vs. 49 +/- 16 pg MT-I/micrograms protein, mean +/- S.D. from three separate cell preparations). Increasing the concentration of Zn in the bovine serum albumin (BSA)-containing culture medium up to 50 microM significantly increased MT-I levels by up to 3.5-fold in neurons and 2.5-fold in astrocytes. In contrast, Cu up to 50 microM increased MT-I levels in a saturable manner in both neurons (up to 5-fold) and astrocytes (up to 1.5-fold), the maximum effect occurring at 5 microM Cu. In general, the combination of Zn and Cu further increased MT-I levels. The effect of the metals on MT-I appeared to reflect metal uptake, since MT-I induction was less marked when the BSA concentration in the medium was increased from 2 to 10 mg/ml. Dexamethasone increased MT-I levels in both neurons and astrocytes in vitro in a concentration-dependent manner. Endotoxin, IL-1 and IL-6 did not have a significant effect on glial MT levels at the concentrations studied. The administration of dexamethasone to rats increased MT-I levels in non-frontal cortex, cerebellum, pons+medulla, midbrain and hippocampus, but not in hypothalamus, frontal cortex and striatum. Endotoxin increased liver but not brain MT-I levels. Immunocytochemical studies in adult rat brain preparations with a polyclonal antibody that cross-reacts with MT-I and MT-II indicated that immunostaining was always nuclear in glial cells, whereas in neurons it was nuclear in the cerebral cortex, hippocampus and the granular layer of the cerebellum, and nuclear plus cytoplasmic in Purkinje cells in the cerebellum, hypothalamic nuclei and gigantocellular reticular nucleus in the brain stem. Meninges, choroidal plexus, ependymal and endothelial cells were also MT-immunoreactive.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923440     DOI: 10.1016/0009-2797(94)90020-5

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  13 in total

1.  Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles.

Authors:  Eva M Luther; Maike M Schmidt; Joerg Diendorf; Matthias Epple; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-04-05       Impact factor: 3.996

2.  Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury.

Authors:  Roger S Chung; Milena Penkowa; Justin Dittmann; Carolyn E King; Carole Bartlett; Johanne W Asmussen; Juan Hidalgo; Javier Carrasco; Yee Kee J Leung; Adam K Walker; Samantha J Fung; Sarah A Dunlop; Melinda Fitzgerald; Lyn D Beazley; Meng I Chuah; James C Vickers; Adrian K West
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

Review 3.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Authors:  Adrian K West; Juan Hidalgo; Donnie Eddins; Edward D Levin; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-01-19       Impact factor: 4.294

Review 4.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

5.  Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice.

Authors:  Shinki Murakami; Ikuko Miyazaki; Norio Sogawa; Ko Miyoshi; Masato Asanuma
Journal:  Neurotox Res       Date:  2014-06-13       Impact factor: 3.911

6.  Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study.

Authors:  M K Viaene; R Masschelein; J Leenders; M De Groof; L J Swerts; H A Roels
Journal:  Occup Environ Med       Date:  2000-01       Impact factor: 4.402

7.  Covalent arylation of metallothionein by oxidized dopamine products: a possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival.

Authors:  Michelle A Gauthier; Joseph K Eibl; James A G Crispo; Gregory M Ross
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

8.  Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice.

Authors:  Hayley Christy Miller; Roan Louw; Michelle Mereis; Gerda Venter; John-Drew Boshoff; Liesel Mienie; Mari van Reenen; Marianne Venter; Jeremie Zander Lindeque; Adán Domínguez-Martínez; Albert Quintana; Francois Hendrikus van der Westhuizen
Journal:  Mol Neurobiol       Date:  2020-09-11       Impact factor: 5.590

9.  A role for transforming growth factor alpha as an inducer of astrogliosis.

Authors:  A G Rabchevsky; J M Weinitz; M Coulpier; C Fages; M Tinel; M P Junier
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

10.  Intracellular dialysis disrupts Zn2+ dynamics and enables selective detection of Zn2+ influx in brain slice preparations.

Authors:  Isamu Aiba; Adrian K West; Christian T Sheline; C William Shuttleworth
Journal:  J Neurochem       Date:  2013-04-22       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.